Skip to content

4151.T

Kyowa Kirin Co.,Ltd.

プライム · 医薬品 · 医薬品 · JP

JPY 2,430.00
+1.67%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue510.6B496.8B495.6B442.2B398.4B
Cost of Revenue30.2B127.9B132.6B111.2B86.9B
Gross Profit88.2B368.9B362.9B331.0B311.5B
Operating Expenses
R&D Expense
SG&A Expense41.1B165.4B167.5B163.1B166.2B
General & Admin Expense
Selling & Marketing Expense
Other Expenses8.1B18.0B19.3B21.0B23.1B
Total Operating Expenses49.2B183.4B186.8B184.1B189.2B
Cost and Expenses104.5B409.6B412.1B345.0B330.8B
Operating Income (EBIT)13.9B87.2B83.5B97.2B67.6B
Non-Operating
Interest Income5.7B4.7B1.8B4.9B3.3B
Interest Expense2.3B3.6B7.5B190.0M1.1B
Net Interest Income3.4B1.1B(5.8B)4.7B2.2B
Other Non-Op Income/Expense385.0M1.1B13.1B16.8B1.7B
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)13.9B87.2B83.5B97.2B67.6B
Income Tax Expense1.9B20.2B23.6B16.1B14.0B
Bottom Line
Net Income72.9B67.0B59.9B81.2B53.6B
Earnings from Cont. Ops
Earnings from Discont. Ops
Bottom Line Net Income72.9B67.0B59.9B81.2B53.6B
Per Share
Basic EPS¥139¥128¥113¥151¥100
Diluted EPS¥139¥128¥113¥151¥100
Revenue Per Share¥975¥949¥936¥823¥741
Shares
Basic Shares Outstanding523.5M523.5M529.5M537.6M537.4M
Diluted Shares Outstanding
Profitability Metrics
EBITDA21.6B113.4B108.2B118.3B86.0B
D&A7.6B26.1B24.8B21.1B18.5B
EBIT13.9B87.2B83.5B97.2B67.6B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026